THE IMPACT OF INTERMITTENT FASTING ON WEIGHT REDUCTION AND METABOLIC PARAMETERS — CURRENT STATE OF KNOWLEDGE
Authors:
- Aleksandra StraszewskaASAleksandra Straszewska
- Aleksandra WoźniakAWAleksandra Woźniak
- Patrycja SobantkaPSPatrycja Sobantka
- Szymon MokrzeckiSMSzymon Mokrzecki
- Matylda KrólMKMatylda Król
- Katarzyna AleksandrowiczKAKatarzyna Aleksandrowicz
- Zofia GrodzkaZGZofia Grodzka
- Mateusz MeszkaMMMateusz Meszka
- Ewa BełcEBEwa Bełc
- Karolina BrzezińskaKBKarolina Brzezińska
- Anna MamachAMAnna Mamach
Open Access
- 31 August 2026
- journal article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
Abstract
Background: Intermittent fasting (IF) has emerged as a widely investigated dietary strategy for the management of obesity and metabolic disorders. Increasing evidence suggests that periodic energy restriction may improve body weight and metabolic parameters associated with cardiovascular disease and type 2 diabetes. Aim: This review aimed to summarize the current evidence regarding the effects of intermittent fasting on body weight reduction, glucose–insulin metabolism, lipid profile, blood pressure, and inflammatory markers. Methods: A narrative review of the literature indexed in PubMed was conducted, focusing primarily on publications from 2020–2025, including randomized controlled trials, systematic reviews, umbrella reviews, and meta-analyses evaluating intermittent fasting in adults with overweight, obesity, metabolic syndrome, or type 2 diabetes. Results: Current evidence indicates that IF may promote moderate weight reduction, decrease visceral adiposity, improve insulin sensitivity, reduce fasting glucose and triglyceride concentrations, and modestly lower blood pressure. Early time-restricted eating appears particularly beneficial due to its alignment with circadian rhythms. However, most studies demonstrate that IF does not significantly outperform conventional caloric restriction when total energy deficit is comparable. Conclusions: Intermittent fasting represents a promising nutritional strategy for improving metabolic health, particularly in individuals with obesity and metabolic syndrome. Nevertheless, long-term adherence, dietary quality, and sustained energy deficit remain the primary determinants of clinical effectiveness. Further long-term randomized controlled trials are required to establish the optimal IF protocols and their long-term safety.Keywords
This publication has 39 references indexed in Scilit:
- Early time‐restricted eating compared with daily caloric restriction: A randomized trial in adults with obesityObesity, 2022
- Effect of early time-restricted feeding on the metabolic profile of adults with excess weight: A systematic review with meta-analysisClinical Nutrition, 2021
- Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and ObesityJAMA Internal Medicine, 2020
- Time‐Restricted Feeding Improves Glucose Tolerance in Men at Risk for Type 2 Diabetes: A Randomized Crossover TrialObesity, 2019
- Intermittent Fasting: Is the Wait Worth the Weight?Current Obesity Reports, 2018
- Flipping the Metabolic Switch: Understanding and Applying the Health Benefits of FastingObesity, 2017
- Impact of intermittent fasting on health and disease processesAgeing Research Reviews, 2017
- Effect of Alternate-Day Fasting on Weight Loss, Weight Maintenance, and Cardioprotection Among Metabolically Healthy Obese AdultsJAMA Internal Medicine, 2017
- Fasting, Circadian Rhythms, and Time-Restricted Feeding in Healthy LifespanCell Metabolism, 2016
- Time-Restricted Feeding Is a Preventative and Therapeutic Intervention against Diverse Nutritional ChallengesCell Metabolism, 2014